The global healthcare is undergoing a paradigm shift, moving from episodic, hospital-centric care to continuous, patient-centric, and preventive models. This transition is propelled by the rapid expansion of digital health, an umbrella term encompassing telemedicine, Mobile Health (mHealth) applications, wearable sensors, and health information technologies [1]. Telemedicine platforms have demonstrated notable effectiveness in chronic disease management, mental health support, and post-operative follow-up, reducing hospital readmissions and enhancing patient adherence to treatment plans [2]. Similarly, mHealth applications and wearable devices now enable real-time monitoring of vital signs, activity levels, and medication compliance, generating rich datasets for personalized care and predictive analytics [3].

Concurrently, advances in Artificial Intelligence, particularly in Machine Learning and Deep Learning, have unlocked unprecedented capabilities in data analysis, pattern recognition, and predictive modeling. For example, ML algorithms have been successfully applied to predict hospital readmissions, identify early signs of cardiovascular diseases, and detect anomalies in continuous glucose monitoring for diabetic patients [4]. Deep learning models, especially convolutional neural networks, have achieved radiology-level accuracy in imaging-based diagnosis, including detection of diabetic retinopathy and pulmonary conditions, significantly enhancing clinical decision-making [5].

The integration of AI/ML into digital health ecosystems represents a synergistic fusion, where vast, multimodal data streams generated from digital tools are transformed into actionable clinical insights [6]. Electronic Health Records, Health Information Exchange systems, and cloud-based platforms facilitate interoperability and centralized data aggregation, enabling predictive analytics and population health management [7]. The emergence of the Internet of Medical Things further amplifies these capabilities, connecting wearable devices, remote monitoring sensors, and patient portals to AI-driven analytics systems for continuous and personalized care [3].

Moreover, AI integration supports patient-centered care through personalized recommendations, adaptive telehealth interventions, and digital therapeutics. Virtual consultations enhanced by AI-powered triage tools, symptom checkers, and natural language processing chatbots not only improve access but also reduce clinician workload and optimize resource allocation [8]. Blockchain technologies are being explored to ensure secure, auditable data exchanges, addressing privacy and cybersecurity challenges inherent in digital health environments [9].

This article provides a comprehensive review of the multifaceted role of AI and ML within digital health and telemedicine. Beyond cataloging applications, we delve into the technical mechanisms underlying AI/ML tools, examine case studies demonstrating clinical and operational impact, and critically analyze the challenges of implementation, including data privacy, bias, regulatory compliance, and interoperability. This review aims to provide a state-of-the-art resource for researchers, clinicians, and health technology policymakers, guiding future integration of AI into digital health ecosystems.

Digital health represents an evolution toward continuous, technology-enabled, patient-centered care. It integrates Information and Communication Technologies (ICT) to support disease prevention, monitoring, diagnosis, and treatment across diverse clinical environments. Its ecosystem includes telemedicine, mHealth, wearable devices, Remote Patient Monitoring (RPM), and Health Information Systems (HISs). These components collectively form the foundation for modern, data-driven healthcare delivery [10].

Together, telemedicine, mHealth, wearables, and HIS form an interconnected digital health architecture that enables continuous monitoring, data-driven clinical decision-making, and patient empowerment. From 2019 to 2025, literature consistently reports improvements in clinical outcomes, patient satisfaction, and accessibility when these technologies are integrated cohesively [6]. Yet, challenges remain, including digital literacy gaps, privacy concerns, unequal access to technology, and interoperability limitations, which must be addressed to fully realize the potential of a global digital health ecosystem [22].

Prior to AI integration, digital health systems frequently produced data-rich but information-poor environments, in which vast volumes of patient-generated and system-generated data lacked actionable interpretation. RPM systems, for example, continuously stream physiological measurements (heart rate, oxygen saturation, glucose levels, physical activity, sleep stages); yet clinicians historically struggled to synthesize this high-frequency data into meaningful clinical insights [23]. Studies have shown that without adequate analytical support, RPM programs risk overwhelming providers with alarms, false positives, and fragmented data, ultimately limiting clinical utility and reducing provider adoption [17], [24].

Similarly, early telemedicine implementations lacked the decision-support infrastructure available in in-person settings. Virtual encounters often proceeded without integrated access to clinical guidelines, risk calculators, or automated triage systems, resulting in variability in diagnostic accuracy and inconsistent care quality[11], [12]. The absence of advanced analytics meant that clinicians relied solely on patient self-reporting and static records, further constraining the effectiveness of remote care for complex or multi-morbid patients.

AI and ML have emerged as the essential cognitive layer that addresses these limitations. By transforming heterogeneous data streams into interpretable knowledge, AI enables automated pattern detection, anomaly identification, and predictive modeling far beyond human perceptual and cognitive capacity [25]. ML models can identify subtle physiological trends that signal early disease progression, such as precursors to cardiac decompensation, respiratory decline, or glycemic instability, enabling proactive interventions rather than reactive care [4], [18].

DL architectures, including recurrent and CNNs, now support real-time analysis of multimodal data from wearables, EHRs, and telehealth platforms. These systems provide personalized risk scores, adaptive treatment recommendations, and automated triage, thereby enhancing clinical decision-making during remote consultations [9]. NLP integrated into telemedicine workflows further assists clinicians by summarizing patient histories, extracting key symptoms, and generating structured documentation during virtual visits [8]. Overall, AI and ML shift digital health from simple data collection toward sophisticated, predictive, and patient-tailored care delivery. Their integration transforms previously overwhelming data ecosystems into scalable infrastructures for precision medicine, enabling care that is timely, informed, and optimized across diverse clinical conditions [6].

Medical imaging represents one of the earliest and most successful domains in which AI and ML have demonstrated clinical value. The increasing availability of high-resolution imaging modalities and the rapid progress in DL architectures; particularly CNNs, Vision Transformers (ViTs), and hybrid models have enabled the automated detection, classification, segmentation, and prognostication of a wide spectrum of diseases [26].

With the rise of telemedicine, AI-powered point-of-care diagnostic tools have gained significant traction; these systems leverage smartphone cameras, portable sensors, and cloud-based inference engines to support diagnostic decision-making in remote locations.

Examples include:

I. Dermatology: AI classifiers analyzing smartphone images for melanoma, basal cell carcinoma, and other skin lesions show diagnostic accuracy approaching that of board-certified dermatologists [34].

II. Otolaryngology: AI-enabled otoscopy systems can detect otitis media or tympanic membrane perforation using smartphone-attached otoscopes, improving primary care diagnostic performance [35].

III. Cardiology: Smartphone-based ECG acquisition combined with AI algorithms enables rapid detection of atrial fibrillation and conduction abnormalities, reducing the need for in-clinic diagnostics [36].

These tools decentralize diagnostic services, enabling near real-time interpretation and clinical guidance during virtual consultations. They also support community-level screening, allowing early detection in regions lacking specialist availability [37].

Building on the cognitive layer that AI/ML adds to digital health ecosystems, predictive analytics represents the point where raw data streams translate into actionable clinical foresight. Once AI overcomes the "data-rich but information-poor" challenge of traditional RPM and telemedicine systems, it unlocks the ability to anticipate patient needs before complications arise. This transformation marks a fundamental shift from reactive intervention to truly proactive and preventive care.

AI/ML models learn temporal patterns across multimodal datasets, including continuous physiologic data from wearables, EHR histories, imaging, behavioral metrics, and even patient-reported outcomes to identify risk trajectories with a level of precision unattainable through human monitoring alone. As health systems transition toward value-based care, these predictive capabilities have become essential for improving outcomes and reducing avoidable hospitalizations.

I. Early warning systems: Predictive algorithms trained on longitudinal RPM data (e.g., heart-rate variability, respiratory trends, mobility signals) and EHR inputs (vital signs, lab values) can detect subtle physiological instability hours before clinical deterioration becomes apparent. For example, machine-learning–based early warning systems have demonstrated the ability to anticipate sepsis onset or heart-failure decompensation significantly earlier than traditional scoring methods [38]. These "digital biomarkers" are now being integrated into hospital command centers and virtual clinical monitoring hubs, reducing code-blue events and preventing unnecessary ICU transfers.

II. Chronic disease management: AI-enabled chronic care systems go beyond simple threshold-based alerts. In diabetes management, advanced models fuse CGM data with information on meals, insulin dosing, and activity patterns to forecast glycemic fluctuations and recommend individualized insulin adjustments. These capabilities form the backbone of next-generation automated insulin delivery; often referred to as the "artificial pancreas" [10]. Similarly, in cardiovascular care, AI analysis of ECG signals from consumer wearables such as the Apple Watch has shown high accuracy in detecting atrial fibrillation, enabling early therapeutic intervention and reducing stroke risk [16].

III. Precision oncology: In oncology, AI/ML systems combine genomic sequencing, histopathological imaging, radiomics, and clinical histories to model tumor progression and treatment response. These models support oncologists in selecting optimal therapeutic strategies, including immunotherapy eligibility and targeted drug regimens, aligning each patient’s treatment with their unique molecular and clinical profile [39]. As a result, cancer care is increasingly shifting toward personalized and data-driven decision-making.

Through these applications, predictive analytics serves as the connective bridge between data interpretation and individualized clinical action. By transforming continuous digital signals into tailored, anticipatory care pathways, AI not only enhances diagnostic accuracy but also supports sustainable, patient-centered health system models.

As predictive analytics and personalized risk modeling increasingly shape proactive healthcare strategies, the next logical extension lies in transforming the point of interaction between patients and clinicians. Telemedicine (once limited to basic video consultations) has evolved into a data-rich, AI-supported clinical environment. By embedding ML and NLP capabilities directly into virtual care workflows, AI not only enhances diagnostic accuracy but also improves efficiency, accessibility, and overall care quality.

The integration of AI into telehealth addresses longstanding barriers such as incomplete patient histories, inconsistent documentation, clinician time constraints, and the lack of decision-support tools traditionally available only in in-person settings. As a result, the virtual encounter becomes more structured, intelligent, and clinically impactful.

I. Intelligent triage and scheduling: AI-driven chatbots, symptom checkers, and NLP-based virtual intake systems collect preliminary information before the clinician even enters the consultation. These tools perform structured patient interviews, extract relevant medical history, and assess symptom severity to guide patients toward the appropriate level of care, from self-management recommendations to urgent tele-visits or emergency referral [40]. This automated triage reduces unnecessary appointments, streamlines provider workflow, and ensures that critical cases receive timely attention.

II. Clinical documentation support: One of the most significant challenges in telemedicine is the clinician's administrative load, especially in documenting virtual encounters. Generative AI and NLP systems now automate note generation by analyzing audio transcripts, clinician–patient conversations, or dictated summaries. These models can draft encounter notes, problem lists, and even preliminary billing codes, allowing providers to redirect their time toward patient interaction rather than clerical tasks [41]. This improvement results in higher documentation accuracy, faster throughput, and reduced burnout.

III. Real-time Clinical Decision Support (CDS): AI-enabled CDS tools augment the telemedicine encounter in real time. By synthesizing EHR data, RPM inputs, and patient-reported symptoms, these systems offer diagnostic suggestions, flag potential risk patterns, and recommend evidence-based treatment pathways. Emerging models can even analyze visual cues during video calls, such as facial pallor, respiratory effort, or motor abnormalities, pending patient consent, enabling clinicians to detect subtle signs that might otherwise go unnoticed in a virtual setting. This capability transforms telemedicine from a communication tool into a genuinely intelligent clinical platform.

Collectively, these innovations elevate virtual care from a convenient alternative into a high-fidelity, data-driven extension of the modern healthcare system. As AI continues to bridge the gap between remote interactions and advanced clinical capabilities, telemedicine is positioned to play a central role in equitable, scalable, and continuous healthcare delivery.

The integration of AI and ML into the digital health and telemedicine ecosystem represents a transformative milestone in modern healthcare. Across diagnostics, predictive analytics, chronic disease management, and virtual care delivery, AI-enabled systems are reshaping workflows, enhancing clinical accuracy, and enabling personalized, data-driven care at a scale previously unattainable. As demonstrated across recent literature, AI-powered imaging diagnostics now rival expert-level interpretation; predictive algorithms forecast deterioration before it becomes clinically evident; and virtual care platforms increasingly leverage intelligent automation, real-time decision support, and continuous monitoring to close longstanding gaps in access and quality. Despite this unprecedented progress, the full potential of AI in digital health remains contingent on addressing several systemic challenges. Issues related to data quality, algorithmic fairness, model generalizability, privacy, cybersecurity, and regulatory alignment continue to shape the boundaries of safe and ethical deployment. Moreover, the integration of AI into clinical practice requires rethinking traditional workflows, promoting clinician trust, and ensuring patient-centered, transparent design principles.

Looking ahead, the convergence of multimodal data (clinical, genomic, wearable, behavioral), foundation models, and next-generation telemedicine platforms is expected to accelerate the transition from reactive to anticipatory care. AI-driven health ecosystems will increasingly enable precision diagnostics, adaptive treatment pathways, and autonomous early warning systems operating seamlessly in both clinical and home environments. As digital health technologies continue to mature beyond the COVID-19 era and into the next decade, AI and ML will serve as the foundational intelligence layer, bridging data and decision-making, expanding the reach of care, and ultimately contributing to more equitable, efficient, and resilient healthcare systems worldwide.

This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.

All data are included in the text.

The author declares that there is no conflict of interest regarding the publication of this review.